Cargando…
The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas
Morphologic criteria illustrated in WHO guidelines are the most significant prognostic factor in human gliomas, but novel biomarkers are needed to identify patients with a poorer outcome. The present study examined the expression of the oncofetal protein IMP3 in a series of 135 patients affected by...
Autores principales: | Del Gobbo, Alessandro, Vaira, Valentina, Ferrari, Lucia, Patriarca, Carlo, Di Cristofori, Andrea, Ricca, Dario, Caroli, Manuela, Rampini, Paolo, Bosari, Silvano, Ferrero, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324486/ https://www.ncbi.nlm.nih.gov/pubmed/25695077 http://dx.doi.org/10.1155/2015/413897 |
Ejemplares similares
-
Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivo
por: Terrasi, Andrea, et al.
Publicado: (2019) -
The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands
por: Elshafey, Mohamed R., et al.
Publicado: (2016) -
A New Mouse Avatar Model of Non-Small Cell Lung Cancer
por: Russo, Maria Veronica, et al.
Publicado: (2015) -
An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs
por: Hirayama, Masatoshi, et al.
Publicado: (2016) -
Dicer loss and recovery induce an oncogenic switch driven by transcriptional activation of the oncofetal Imp1–3 family
por: JnBaptiste, Courtney K., et al.
Publicado: (2017)